Cleared Traditional

K801720 - TOXO BIO-BEAD TITRATION KIT

K801720 is the FDA 510(k) clearance for TOXO BIO-BEAD TITRATION KIT by Litton Bionetics. It is a Class 2 Microbiology device (product code GLZ) cleared through the Traditional 510(k) pathway after a 55-day FDA review.

K801720 · Litton Bionetics · Microbiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 1980
Decision
55d
Days
Class 2
Risk

K801720 is an FDA 510(k) clearance for the TOXO BIO-BEAD TITRATION KIT. Classified as Antigens, If, Toxoplasma Gondii (product code GLZ), Class II - Special Controls.

Submitted by Litton Bionetics (Mchenry, US). The FDA issued a Cleared decision on September 16, 1980 after a review of 55 days - a notably fast clearance cycle.

This device falls under the Microbiology FDA review panel, regulated under 21 CFR 866.3780 - the FDA microbiology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Litton Bionetics devices

Submission Details

510(k) Number K801720 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 23, 1980
Decision Date September 16, 1980
Days to Decision 55 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
47d faster than avg
Panel avg: 102d · This submission: 55d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code GLZ Antigens, If, Toxoplasma Gondii
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 866.3780
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Microbiology devices follow this clearance model.

Regulatory Peers - GLZ Antigens, If, Toxoplasma Gondii

All 7
Devices cleared under the same product code (GLZ) and FDA review panel - the closest regulatory comparables to K801720.
TOXOPLASMA IGM IFA TEST SYSTEM
K924882 · Zeus Scientific, Inc. · Mar 1993
TOXO IGM TEST
K880007 · Gull Laboratories, Inc. · Mar 1988
ANTI-TOXOPLASMA GONDII KIT
K842664 · Amico Lab, Inc. · Aug 1984
TOXOPLASMA ANTIBODY TEST SYSTEM
K791571 · Zeus Scientific, Inc. · Sep 1979
QUANTAZYME TOXOPLASMA
K790360 · Bio-Rad · May 1979
IMMUNOZYME TOXOPLASMA ANTIBODY
K780352 · Millipore Corp. · Jun 1978